Skip to main content

LEVIN CAPITAL STRATEGIES, L.P.

Position in PRME — Prime Medicine, Inc.

CIK 1354821 NEW YORK, NY

Position in PRME

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$52,200
+$150 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Derivatives in PRME

reported options exposure · as of Sep 30, 2024
CallValue
$154,800
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

LEVIN CAPITAL STRATEGIES, L.P. holds $12,744,736 across 8 Biotechnology names. PRME ranks #7 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 PRME
Prime Medicine, Inc.
This page
15,000 $52,200

All Filings in PRME

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $52,200 15,000
2025-12-31 $52,050 15,000
2025-09-30 $83,100 15,000
2025-06-30 $345,800 140,000
2025-03-31 $69,650 35,000
2024-12-31 $219,000 75,000
2024-09-30 $116,100 30,000
2024-09-30 $154,800 40,000
2024-03-31 $185,500 26,500
2023-12-31 $177,200 20,000
2023-06-30 $293,000 20,000
2022-12-31 $196,669 10,585